| Panel | Analytes |
| 1 | CXCL8 (IL-8), IL-11, IL-12/IL-23 p40, IL-19, IL-27, IL-34, IL-6Rα, gp130, IFN-β MMP-1, MMP-3 Chitinase 3-like 1, CD163, pentraxin-3, APRIL, BAFF, osteopontin, aggrecan |
| 2 | IL-2, IL-4, IL-5, IL-6, IL-10, IL-13 CCL3 (MIP-1α), CCL4 (MIP-1β) GM-CSF, TNF-α, IFN-g, 4-1BB Fas, Fas Ligand, granzyme B |
| 3 | IL-1β, IL-12 p70, IL-15, IL-17 (IL-17A), IL-17E (IL-25), IL-21, IL-23, IL-28A, IL-31, IL-33 CCL20 (MIP-3α), CD40 Ligand, TNF-β |
| 4 | CD30, TNF-RI, TNF-RII |
| 5 | CCL5 (RANTES), BCMA, MMP-2 |
| 6 | Perforin |
| 7 | Granzyme A |
| Panel | Analytes |
| 1 | CXCL8 (IL-8), IL-11, IL-12/IL-23 p40, IL-19, IL-27, IL-34, IL-6Rα, gp130, IFN-β MMP-1, MMP-3 Chitinase 3-like 1, CD163, pentraxin-3, APRIL, BAFF, osteopontin, aggrecan |
| 2 | IL-2, IL-4, IL-5, IL-6, IL-10, IL-13 CCL3 (MIP-1α), CCL4 (MIP-1β) GM-CSF, TNF-α, IFN-g, 4-1BB Fas, Fas Ligand, granzyme B |
| 3 | IL-1β, IL-12 p70, IL-15, IL-17 (IL-17A), IL-17E (IL-25), IL-21, IL-23, IL-28A, IL-31, IL-33 CCL20 (MIP-3α), CD40 Ligand, TNF-β |
| 4 | CD30, TNF-RI, TNF-RII |
| 5 | CCL5 (RANTES), BCMA, MMP-2 |
| 6 | Perforin |
| 7 | Granzyme A |
Bold text indicates the 22 analytes with a sufficiently high fold increase in MFI values to be included in the statistical analysis.
Abbreviations: APRIL, a proliferation-inducing ligand; BAFF, B-cell activating factor; BCMA, B-cell maturation antigen; IFN-β, interferon-β; IL, interleukin; GM-CSF, granulocyte macrophage colony-stimulating factor; MMP-1, matrix metalloproteinase-1; TNF-RII, tumor necrosis factor receptor II.
| Panel | Analytes |
| 1 | CXCL8 (IL-8), IL-11, IL-12/IL-23 p40, IL-19, IL-27, IL-34, IL-6Rα, gp130, IFN-β MMP-1, MMP-3 Chitinase 3-like 1, CD163, pentraxin-3, APRIL, BAFF, osteopontin, aggrecan |
| 2 | IL-2, IL-4, IL-5, IL-6, IL-10, IL-13 CCL3 (MIP-1α), CCL4 (MIP-1β) GM-CSF, TNF-α, IFN-g, 4-1BB Fas, Fas Ligand, granzyme B |
| 3 | IL-1β, IL-12 p70, IL-15, IL-17 (IL-17A), IL-17E (IL-25), IL-21, IL-23, IL-28A, IL-31, IL-33 CCL20 (MIP-3α), CD40 Ligand, TNF-β |
| 4 | CD30, TNF-RI, TNF-RII |
| 5 | CCL5 (RANTES), BCMA, MMP-2 |
| 6 | Perforin |
| 7 | Granzyme A |
| Panel | Analytes |
| 1 | CXCL8 (IL-8), IL-11, IL-12/IL-23 p40, IL-19, IL-27, IL-34, IL-6Rα, gp130, IFN-β MMP-1, MMP-3 Chitinase 3-like 1, CD163, pentraxin-3, APRIL, BAFF, osteopontin, aggrecan |
| 2 | IL-2, IL-4, IL-5, IL-6, IL-10, IL-13 CCL3 (MIP-1α), CCL4 (MIP-1β) GM-CSF, TNF-α, IFN-g, 4-1BB Fas, Fas Ligand, granzyme B |
| 3 | IL-1β, IL-12 p70, IL-15, IL-17 (IL-17A), IL-17E (IL-25), IL-21, IL-23, IL-28A, IL-31, IL-33 CCL20 (MIP-3α), CD40 Ligand, TNF-β |
| 4 | CD30, TNF-RI, TNF-RII |
| 5 | CCL5 (RANTES), BCMA, MMP-2 |
| 6 | Perforin |
| 7 | Granzyme A |
Bold text indicates the 22 analytes with a sufficiently high fold increase in MFI values to be included in the statistical analysis.
Abbreviations: APRIL, a proliferation-inducing ligand; BAFF, B-cell activating factor; BCMA, B-cell maturation antigen; IFN-β, interferon-β; IL, interleukin; GM-CSF, granulocyte macrophage colony-stimulating factor; MMP-1, matrix metalloproteinase-1; TNF-RII, tumor necrosis factor receptor II.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
